Skip to main content

Table 1 Acinetobacter baumannii isolates in this study and their MICs

From: Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients

Isolates Infection Sample Clonotype COL (μg/mL) MEM (μg/mL) MINO (μg/mL) RFP (μg/mL)
09-95 VAP Sputum I 0.25 32 4 4
09-154 VAP Sputum I 0.25 16 4 8
09-1769 VAP Sputum II 0.5 64 8 4
09-1782 VAP Sputum I 0.5 16 4 8
09-2092 VAP Sputum I 0.25 128 8 4
09-2221 VAP Sputum I 0.5 64 4 4
09-2902 CB Sputum III 0.5 16 4 4
10-39 CB Sputum I 0.5 64 2 8
10-161 CB Sputum I 0.25 64 2 4
10-415 II CSF I 0.5 64 2 4
10-533 VAP Sputum I 0.25 16 4 8
10-548 HAP Sputum IV 0.5 64 4 16
10-584 VAP Sputum IV 0.5 64 4 8
10-617 CB Sputum IV 0.5 32 2 8
  1. MIC = minimum inhibitory concentration, VAP = ventilator-associated pneumonia, HAP = hospital-acquired pneumonia, CB = colonized bacteria, II = intracranial infection, CSF = cerebrospinal fluid, COL = colistin (breakpoint = 2 μg/mL), MEM = meropenem (breakpoint = 16 μg/mL), MINO = minocycline (breakpoint = 16 μg/mL), RFP = rifampicin (no breakpoint is available).